Related Experiment Video
Updated: Aug 23, 2026

Functional Complementation Analysis (FCA): A Laboratory Exercise Designed and Implemented to Supplement the Teaching of Biochemical Pathways
Published on: June 24, 2016
[Executive functions in children with phenylketonuria: variations as a function of phenilalanine plasm level]
Leandro Fernandes Malloy-Diniz1, Cláudia Cardoso-Martins, Karina Cunha Carneiro
1Núcleo de Neurociências e Análise Experimental do Comportamento do Curso de Psicologia, Faculdade Metropolitana, Belo Horizonte, MG, Brasil.
Insights
Children with high phenylalanine levels in Phenilketonuria (PKU) show executive function deficits. This study highlights the impact of phenylalanine on cognitive development in infants with PKU.
Area of Science:
- Neuroscience
- Developmental Psychology
- Metabolic Disorders
Context:
- Phenilketonuria (PKU) is a rare genetic disorder requiring early and continuous treatment.
- Elevated phenylalanine levels can impact brain development.
- Executive functions are crucial for cognitive control and behavior.
Purpose:
- To investigate executive function deficits in infants with Phenilketonuria (PKU).
- To determine if high phenylalanine levels are associated with specific cognitive impairments in PKU patients.
Summary:
- This study compared 9-month-old infants with PKU (divided into low and high phenylalanine groups) to healthy controls.
- While global mental development was similar across groups, infants with PKU and phenylalanine levels between 360-600 mmol/l performed significantly worse on executive function tasks.
- This suggests a specific executive function deficit linked to higher phenylalanine levels in early PKU.
Impact:
- Findings indicate that elevated phenylalanine levels in early childhood PKU may specifically impair executive functions.
- This research underscores the importance of maintaining optimal phenylalanine control for cognitive development in infants with PKU.
- Results may inform therapeutic strategies and monitoring protocols for children with PKU.
Abstract:
The present study investigates the hypothesis of a specific executive function deficit in children with Phenilketonuria (PKU) whose Phenilalanine level is between 360 and 600 mmol/l. Participants were 21 early and continuously treated 9-month-old children with PKU and 18 9-month-old controls. The children with PKU were divided into two groups on the basis of their mean phenilalanine level prior to the study: the group of children whose level was between 120 and 360 mmol/l, and the group of children whose level was between 360 and 600 mmol/l. Although the three groups did not differ with regard to performance on a test of global mental development, the PKU children with high phenilalanine performed significantly worse than both the low phenilalanine PKU children and the control children on a task that assesses executive functioning.
More Related Videos
Related Concept Videos
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

